Iterum Therapeutics downgraded by HC Wainwright & Co.
$ITRM
Biotechnology: Pharmaceutical Preparations
Health Care
HC Wainwright & Co. downgraded Iterum Therapeutics from Buy to Neutral
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
7/27/2021 | Sell → Hold | Gabelli & Co. | |
7/26/2021 | Buy → Neutral | HC Wainwright & Co. |